BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19936332)

  • 1. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis.
    Okazumi S; Dimitrakopoulou-Strauss A; Schwarzbach MH; Strauss LG
    Hell J Nucl Med; 2009; 12(3):223-8. PubMed ID: 19936332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
    Dimitrakopoulou-Strauss A; Strauss LG; Schwarzbach M; Burger C; Heichel T; Willeke F; Mechtersheimer G; Lehnert T
    J Nucl Med; 2001 May; 42(5):713-20. PubMed ID: 11337565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
    Dimitrakopoulou-Strauss A; Strauss LG; Heichel T; Wu H; Burger C; Bernd L; Ewerbeck V
    J Nucl Med; 2002 Apr; 43(4):510-8. PubMed ID: 11937595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
    Dimitrakopoulou-Strauss A; Strauss L
    Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss A; Strauss LG; Burger C; Rühl A; Irngartinger G; Stremmel W; Rudi J
    J Nucl Med; 2004 Sep; 45(9):1480-7. PubMed ID: 15347714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
    Dimitrakopoulou-Strauss A; Strauss LG; Egerer G; Vasamiliette J; Schmitt T; Haberkorn U; Kasper B
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1481-9. PubMed ID: 20336454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
    Dimitrakopoulou-Strauss A; Hoffmann M; Bergner R; Uppenkamp M; Haberkorn U; Strauss LG
    Clin Nucl Med; 2009 Sep; 34(9):576-84. PubMed ID: 19692817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
    Dimitrakopoulou-Strauss A; Strauss LG; Egerer G; Vasamiliette J; Mechtersheimer G; Schmitt T; Lehner B; Haberkorn U; Stroebel P; Kasper B
    J Nucl Med; 2010 Apr; 51(4):551-8. PubMed ID: 20351350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
    Koukouraki S; Strauss LG; Georgoulias V; Eisenhut M; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1115-22. PubMed ID: 16763820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
    Fendler WP; Chalkidis RP; Ilhan H; Knösel T; Herrmann K; Issels RD; Bartenstein P; Cyran CC; Lindner LH; Hacker M
    Eur Radiol; 2015 Aug; 25(8):2214-21. PubMed ID: 25693667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
    Dimitrakopoulou-Strauss A; Strauss LG; Rudi J
    Q J Nucl Med; 2003 Mar; 47(1):8-13. PubMed ID: 12714949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
    Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ
    Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
    Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis.
    Ioannidis JP; Lau J
    J Nucl Med; 2003 May; 44(5):717-24. PubMed ID: 12732672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG kinetics and gene expression in giant cell tumors.
    Strauss LG; Dimitrakopoulou-Strauss A; Koczan D; Bernd L; Haberkorn U; Ewerbeck V; Thiesen HJ
    J Nucl Med; 2004 Sep; 45(9):1528-35. PubMed ID: 15347720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
    Rusten E; Rødal J; Revheim ME; Skretting A; Bruland OS; Malinen E
    Acta Oncol; 2013 Aug; 52(6):1160-7. PubMed ID: 23198721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.